Circa Group announced a strategic technology partnership with Ekato. The agreement that has been signed with Ekato will see Circa incorporate Ekato’s hydrogenation technology in the development of its ReSolute plant, which will be commissioned in June 2024. The partnership also covers future commercial scale plants including FC6, which is in the planning stages.

Ekato Group is the market leader in hydrogenation technology, which plays a critical role in the production of Cyrene, Circa’s flagship bio-based solvent.

Philip Mathon, Ekato RMT, CEO said: “At EKATO, we have a great strategic interest to cooperate with companies developing innovative processes for production of bio-based chemicals and materials. This long-term cooperation agreement with CIRCA, is therefore, very important to us. As the leading process loop solution provider in hydrogenation technology, we contribute with our long-standing know-how and expertise from engineering to equipment to process solution so as to ensure that CIRCA’s production process captures the synergies of sustainability and profit.”

Tony Duncan, CEO, Circa Group, said “Our contracts with major vendors are a significant milestone as we progress towards the commissioning of ReSolute. By partnering with global leaders of the chemical industry like EKATO, Circa is gaining access to high calibre skills and the latest technology. This strategic partnership positions Circa to work with the best in the field, as we execute our vision to produce 80,000 tonnes of Cyrene by 2030.”